KITAGAWA KAZUO
   Department   Other, Other
   Position  
Article types Original article
Language English
Peer review Peer reviewed
Title Effects of pioglitazone on macrovascular events in patients with type 2 diabetes mellitus at high risk of stroke: the PROFIT-J study.
Journal Formal name:Journal of atherosclerosis and thrombosis
Abbreviation:J Atheroscler Thromb
ISSN code:(1880-3873)1340-3478(Linking)
Domestic / ForeginForegin
Volume, Issue, Page 21(6),pp.563-73
Author and coauthor Yoshii Hidenori, Onuma Tomio, Yamazaki Tsutomu, Watada Hirotaka, Matsuhisa Munehide, Matsumoto Masayasu, Kitagawa Kazuo, Kitakaze Masafumi, Yamasaki Yoshimitsu, Kawamori Ryuzo,
Publication date 2014
Summary Pioglitazone therapy produces immediate and effective improvements in glycemic control, diastolic blood pressure and lipid profiles. While this study was too underpowered to determine the effects of pioglitazone on the incidence of cardiovascular events, the results indicated that two years of pioglitazone treatment did not produce any statistically significant reductions in the rate of primary cardiovascular events.
PMID 24477028